{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-020832","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.894283+00:00","generated_at":"2026-06-01T11:17:26.700924+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Celularity guides Q4 2023 revenue ~$12.1M, Q1 2024 revenue ~$14.8M","bullets":["Preliminary Q4 2023 net revenue ~$12.1M from biomaterial product sales and biobanking services.","Preliminary Q1 2024 net revenue ~$14.8M from the same segments, up ~22% sequentially.","Full-year 2023 and Q1 2024 financials not yet finalized; subject to audit/review adjustments.","Company hosted an Investor & R&D Day on May 21, 2024, with presentation posted on IR website."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-020832","json":"https://secwatch.observer/filing/0001493152-24-020832.json","markdown":"https://secwatch.observer/filing/0001493152-24-020832.md","text":"https://secwatch.observer/filing/0001493152-24-020832.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224020832/0001493152-24-020832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224020832/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T11:17:26.700924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}